Schwarz JK - Search Results

1

Standardized Uptake Value for ¹⁸F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer.

Floberg JM, Zhang J, Muhammad N, DeWees TA, Inkman M, Chen K, Lin AJ, Rashmi R, Jayachandran K, Edelson BT, Siegel BA, Dehdashti F, Grigsby PW, Markovina S, Schwarz JK. Floberg JM, et al. Among authors: schwarz jk. Clin Cancer Res. 2021 Aug 1;27(15):4245-4255. doi: 10.1158/1078-0432.CCR-20-4450. Epub 2021 Apr 5. Clin Cancer Res. 2021. PMID: 33820781 Free PMC article.

2

Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix.

Grigsby PW, Malyapa RS, Higashikubo R, Schwarz JK, Welch MJ, Huettner PC, Dehdashti F. Grigsby PW, et al. Among authors: schwarz jk. Mol Imaging Biol. 2007 Sep-Oct;9(5):278-83. doi: 10.1007/s11307-007-0095-2. Mol Imaging Biol. 2007. PMID: 17431727

3

Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.

Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Schwarz JK, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):180-6. doi: 10.1016/j.ijrobp.2007.09.005. Epub 2007 Nov 8. Int J Radiat Oncol Biol Phys. 2008. PMID: 17996387

4

Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.

Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Schwarz JK, et al. JAMA. 2007 Nov 21;298(19):2289-95. doi: 10.1001/jama.298.19.2289. JAMA. 2007. PMID: 18029833

5

18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.

Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW. Schwarz JK, et al. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1502-7. doi: 10.1016/j.ijrobp.2008.03.040. Epub 2008 Jun 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18538498

6

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.

Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. Schwarz JK, et al. J Nucl Med. 2009 May;50 Suppl 1:64S-73S. doi: 10.2967/jnumed.108.057257. Epub 2009 Apr 20. J Nucl Med. 2009. PMID: 19380409 Free article. Review.

7

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.

Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN, Wang X. Hu X, et al. Among authors: schwarz jk. Gynecol Oncol. 2009 Sep;114(3):457-64. doi: 10.1016/j.ygyno.2009.05.022. Epub 2009 Jun 5. Gynecol Oncol. 2009. PMID: 19501389

8

A microRNA expression signature for cervical cancer prognosis.

Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X. Hu X, et al. Among authors: schwarz jk. Cancer Res. 2010 Feb 15;70(4):1441-8. doi: 10.1158/0008-5472.CAN-09-3289. Epub 2010 Feb 2. Cancer Res. 2010. PMID: 20124485 Free PMC article.

9

Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.

Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK. Olsen JR, et al. Among authors: schwarz jk. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):772-7. doi: 10.1016/j.ijrobp.2010.06.008. Epub 2010 Oct 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20888130

10

Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.

Schwarz JK, Wahab S, Grigsby PW. Schwarz JK, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1258-63. doi: 10.1016/j.ijrobp.2010.07.038. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932657 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters